| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
1.307 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
1.307 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
CRIP2 |
CRIP2, CRP2: Cysteine-rich protein 2 |
1.307 |
Evidence |
|
| ITGA2B |
ITGA2B, GP2B, ITGAB: Integrin alpha-IIb precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
1.307 |
Evidence |
|
| SNCG |
SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein |
NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
1.307 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
1.307 |
Evidence |
|
| CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
LEF1 |
LEF1: Lymphoid enhancer-binding factor 1 |
1.305 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
ARL4D |
ARL4D, ARF4L: ADP-ribosylation factor-like protein 4D |
1.305 |
Evidence |
O
|
| EFNA3 |
EFNA3, EFL2, EPLG3, LERK3: Ephrin-A3 precursor |
MAP3K10 |
MAP3K10, MLK2, MST: Mitogen-activated protein kinase kinase kinase 10 |
1.305 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
UBA52 |
UBA52, UBCEP2: 60S ribosomal protein L40 |
1.305 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
1.305 |
Evidence |
|
| LIFR |
LIFR: Leukemia inhibitory factor receptor precursor |
DUSP4 |
DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 |
1.305 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
TMPRSS11E |
TMPRSS11E, DESC1, UNQ742/PRO1461: Transmembrane protease, serine 11E precursor |
1.305 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
1.305 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
1.305 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
CSK |
CSK: Tyrosine-protein kinase CSK |
1.305 |
Evidence |
|
| TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
JAK1 |
|
1.305 |
Evidence |
|
| SIRPB1 |
SIRPB1: Signal regulatory protein beta-1 precursor |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
1.305 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
1.305 |
Evidence |
|
| CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
1.305 |
Evidence |
|
| CFI |
CFI, IF: Complement factor I precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
1.305 |
Evidence |
|
| AHR |
AHR: Aryl hydrocarbon receptor precursor |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
1.305 |
Evidence |
|
| AGT |
AGT, SERPINA8: Angiotensinogen precursor |
C1S |
C1S: Complement C1s subcomponent precursor |
1.305 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.305 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
1.305 |
Evidence |
|